Understanding the Hsp90 <i>N</i>-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)

Heat shock protein 90 (Hsp90) is a crucial component in carcinogenesis and serves as a molecular chaperone that facilitates protein maturation whilst protecting cells against temperature-induced stress. The function of Hsp90 is highly dependent on adenosine triphosphate (ATP) binding to the <i>...

Full description

Bibliographic Details
Main Authors: Ayanda M. Magwenyane, Ndumiso N. Mhlongo, Monsurat M. Lawal, Daniel G. Amoako, Anou M. Somboro, Sphelele C. Sosibo, Letitia Shunmugam, Rene B. Khan, Hezekiel M. Kumalo
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/8/1785
_version_ 1797570794542333952
author Ayanda M. Magwenyane
Ndumiso N. Mhlongo
Monsurat M. Lawal
Daniel G. Amoako
Anou M. Somboro
Sphelele C. Sosibo
Letitia Shunmugam
Rene B. Khan
Hezekiel M. Kumalo
author_facet Ayanda M. Magwenyane
Ndumiso N. Mhlongo
Monsurat M. Lawal
Daniel G. Amoako
Anou M. Somboro
Sphelele C. Sosibo
Letitia Shunmugam
Rene B. Khan
Hezekiel M. Kumalo
author_sort Ayanda M. Magwenyane
collection DOAJ
description Heat shock protein 90 (Hsp90) is a crucial component in carcinogenesis and serves as a molecular chaperone that facilitates protein maturation whilst protecting cells against temperature-induced stress. The function of Hsp90 is highly dependent on adenosine triphosphate (ATP) binding to the <i>N</i>-terminal domain of the protein. Thus, inhibition through displacement of ATP by means of competitive binding with a suitable organic molecule is considered an attractive topic in cancer research. Radicicol (RD) and its derivative, resorcinylic isoxazole amine NVP-AUY922 (NVP), have shown promising pharmacodynamics against Hsp90 activity. To date, the underlying binding mechanism of RD and NVP has not yet been investigated. In this study, we provide a comprehensive understanding of the binding mechanism of RD and NVP, from an atomistic perspective. Density functional theory (DFT) calculations enabled the analyses of the compounds’ electronic properties and results obtained proved to be significant in which NVP was predicted to be more favorable with solvation free energy value of −23.3 kcal/mol and highest stability energy of 75.5 kcal/mol for a major atomic delocalization. Molecular dynamic (MD) analysis revealed NVP bound to Hsp90 (NT-NVP) is more stable in comparison to RD (NT-RD). The Hsp90 protein exhibited a greater binding affinity for NT-NVP (−49.4 ± 3.9 kcal/mol) relative to NT-RD (−28.9 ± 4.5 kcal/mol). The key residues influential in this interaction are Gly 97, Asp 93 and Thr 184. These findings provide valuable insights into the Hsp90 dynamics and will serve as a guide for the design of potent novel inhibitors for cancer treatment.
first_indexed 2024-03-10T20:30:27Z
format Article
id doaj.art-dd39f11f5f4e451781cb2b9b520e038d
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T20:30:27Z
publishDate 2020-04-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-dd39f11f5f4e451781cb2b9b520e038d2023-11-19T21:30:58ZengMDPI AGMolecules1420-30492020-04-01258178510.3390/molecules25081785Understanding the Hsp90 <i>N</i>-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)Ayanda M. Magwenyane0Ndumiso N. Mhlongo1Monsurat M. Lawal2Daniel G. Amoako3Anou M. Somboro4Sphelele C. Sosibo5Letitia Shunmugam6Rene B. Khan7Hezekiel M. Kumalo8Drug Research and Innovation Unit, Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban 4000, South AfricaDrug Research and Innovation Unit, Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban 4000, South AfricaDrug Research and Innovation Unit, Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban 4000, South AfricaDrug Research and Innovation Unit, Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban 4000, South AfricaDrug Research and Innovation Unit, Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban 4000, South AfricaSchool of Physical and Chemical Sciences, Department of Chemistry, North West University, Mafikeng Campus, Mmabatho 2790, South AfricaDrug Research and Innovation Unit, Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban 4000, South AfricaDrug Research and Innovation Unit, Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban 4000, South AfricaDrug Research and Innovation Unit, Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban 4000, South AfricaHeat shock protein 90 (Hsp90) is a crucial component in carcinogenesis and serves as a molecular chaperone that facilitates protein maturation whilst protecting cells against temperature-induced stress. The function of Hsp90 is highly dependent on adenosine triphosphate (ATP) binding to the <i>N</i>-terminal domain of the protein. Thus, inhibition through displacement of ATP by means of competitive binding with a suitable organic molecule is considered an attractive topic in cancer research. Radicicol (RD) and its derivative, resorcinylic isoxazole amine NVP-AUY922 (NVP), have shown promising pharmacodynamics against Hsp90 activity. To date, the underlying binding mechanism of RD and NVP has not yet been investigated. In this study, we provide a comprehensive understanding of the binding mechanism of RD and NVP, from an atomistic perspective. Density functional theory (DFT) calculations enabled the analyses of the compounds’ electronic properties and results obtained proved to be significant in which NVP was predicted to be more favorable with solvation free energy value of −23.3 kcal/mol and highest stability energy of 75.5 kcal/mol for a major atomic delocalization. Molecular dynamic (MD) analysis revealed NVP bound to Hsp90 (NT-NVP) is more stable in comparison to RD (NT-RD). The Hsp90 protein exhibited a greater binding affinity for NT-NVP (−49.4 ± 3.9 kcal/mol) relative to NT-RD (−28.9 ± 4.5 kcal/mol). The key residues influential in this interaction are Gly 97, Asp 93 and Thr 184. These findings provide valuable insights into the Hsp90 dynamics and will serve as a guide for the design of potent novel inhibitors for cancer treatment.https://www.mdpi.com/1420-3049/25/8/1785Hsp90 protease<i>N</i>-terminalradicicolNVP-AUY922density functional theory (DFT)molecular dynamics (MD)
spellingShingle Ayanda M. Magwenyane
Ndumiso N. Mhlongo
Monsurat M. Lawal
Daniel G. Amoako
Anou M. Somboro
Sphelele C. Sosibo
Letitia Shunmugam
Rene B. Khan
Hezekiel M. Kumalo
Understanding the Hsp90 <i>N</i>-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)
Molecules
Hsp90 protease
<i>N</i>-terminal
radicicol
NVP-AUY922
density functional theory (DFT)
molecular dynamics (MD)
title Understanding the Hsp90 <i>N</i>-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)
title_full Understanding the Hsp90 <i>N</i>-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)
title_fullStr Understanding the Hsp90 <i>N</i>-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)
title_full_unstemmed Understanding the Hsp90 <i>N</i>-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)
title_short Understanding the Hsp90 <i>N</i>-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)
title_sort understanding the hsp90 i n i terminal dynamics structural and molecular insights into the therapeutic activities of anticancer inhibitors radicicol rd and radicicol derivative nvp yua922
topic Hsp90 protease
<i>N</i>-terminal
radicicol
NVP-AUY922
density functional theory (DFT)
molecular dynamics (MD)
url https://www.mdpi.com/1420-3049/25/8/1785
work_keys_str_mv AT ayandammagwenyane understandingthehsp90initerminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT ndumisonmhlongo understandingthehsp90initerminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT monsuratmlawal understandingthehsp90initerminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT danielgamoako understandingthehsp90initerminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT anoumsomboro understandingthehsp90initerminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT sphelelecsosibo understandingthehsp90initerminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT letitiashunmugam understandingthehsp90initerminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT renebkhan understandingthehsp90initerminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT hezekielmkumalo understandingthehsp90initerminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922